Discovery of DNA methylation markers in cervical cancer using relaxation ranking

被引：34

作者：

Ongenaert, Mate ^{[2
]}

Wisman, G. Bea A. ^{[1
]}

Volders, Haukeline H. ^{[1
]}

Koning, Alice J. ^{[1
]}

van der Zee, Ate G. J. ^{[1
]}

van Criekinge, Wim ^{[2
,3
]}

Schuuring, Ed ^{[4
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Gynaecol Oncol, NL-9700 AB Groningen, Netherlands

[2] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Lab Bioinformat & Computat Genom BioBix, Ghent, Belgium

[3] Oncomethylome Sci SA, Liege, Belgium

[4] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, NL-9700 AB Groningen, Netherlands

来源：

BMC MEDICAL GENOMICS | 2008年 / 1卷 / 1期

关键词：

D O I：

10.1186/1755-8794-1-57

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Background: To discover cancer specific DNA methylation markers, large-scale screening methods are widely used. The pharmacological unmasking expression microarray approach is an elegant method to enrich for genes that are silenced and re-expressed during functional reversal of DNA methylation upon treatment with demethylation agents. However, such experiments are performed in in vitro (cancer) cell lines, mostly with poor relevance when extrapolating to primary cancers. To overcome this problem, we incorporated data from primary cancer samples in the experimental design. A strategy to combine and rank data from these different data sources is essential to minimize the experimental work in the validation steps. Aim: To apply a new relaxation ranking algorithm to enrich DNA methylation markers in cervical cancer. Results: The application of a new sorting methodology allowed us to sort high-throughput microarray data from both cervical cancer cell lines and primary cervical cancer samples. The performance of the sorting was analyzed in silico. Pathway and gene ontology analysis was performed on the top-selection and gives a strong indication that the ranking methodology is able to enrich towards genes that might be methylated. Terms like regulation of progression through cell cycle, positive regulation of programmed cell death as well as organ development and embryonic development are overrepresented. Combined with the highly enriched number of imprinted and X-chromosome located genes, and increased prevalence of known methylation markers selected from cervical (the highest-ranking known gene is CCNA1) as well as from other cancer types, the use of the ranking algorithm seems to be powerful in enriching towards methylated genes. Verification of the DNA methylation state of the 10 highest-ranking genes revealed that 7/9 (78%) gene promoters showed DNA methylation in cervical carcinomas. Of these 7 genes, 3 (SST, HTRA3 and NPTX1) are not methylated in normal cervix tissue. Conclusion: The application of this new relaxation ranking methodology allowed us to significantly enrich towards methylation genes in cancer. This enrichment is both shown in silico and by experimental validation, and revealed novel methylation markers as proof-of-concept that might be useful in early cancer detection in cervical scrapings.

引用

页数：15

共 78 条

[11] Computational prediction of methylation status in human genomic sequences [J].

Das, Rajdeep ;

Dimitrova, Nevenka ;

Xuan, Zhenyu ;

Rollins, Robert A. ;

Haghighi, Fatemah ;

Edwards, John R. ;

Ju, Jingyue ;

Bestor, Timothy H. ;

Zhang, Michael Q. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (28) :10713-10716

[12] EUKARYOTIC DNA METHYLATION - FACTS AND PROBLEMS [J].

DOERFLER, W ;

TOTH, M ;

KOCHANEK, S ;

ACHTEN, S ;

FREISEMRABIEN, U ;

BEHNKRAPPA, A ;

OREND, G .

FEBS LETTERS, 1990, 268 (02) :329-333

[13] Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines [J].

Dowdy, SC ;

Gostout, BS ;

Shridhar, V ;

Wu, XS ;

Smith, DI ;

Podratz, KC ;

Jiang, SW .

GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :126-134

[14]

Esteller M, 2003, ADV EXP MED BIOL, V532, P39

[15] Cancer epigenomics: DNA methylomes and histone-modification maps [J].

Esteller, Manel .

NATURE REVIEWS GENETICS, 2007, 8 (04) :286-298

[16] Predicting aberrant CpG island methylation [J].

Feltus, FA ;

Lee, EK ;

Costello, JF ;

Plass, C ;

Vertino, PM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12253-12258

[17] Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation [J].

Feng, Weiwei ;

Marquez, Rebecca T. ;

Lu, Zhen ;

Liu, Jinsong ;

Lu, Karen H. ;

Issa, Jean-Pierre J. ;

Fishman, David M. ;

Yu, Yinhua ;

Bast, Robert C., Jr. .

CANCER, 2008, 112 (07) :1489-1502

[18] Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Does the new staging system predict morbidity and survival? [J].

Finan, MA ;

DeCesare, S ;

Fiorica, JV ;

Chambers, R ;

Hoffman, MS ;

Kline, RC ;

Roberts, WS ;

Cavanagh, D .

GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :139-147

[19]

Fradet Y, 2006, PROG UROL, V16, P421

[20] Bioconductor: open software development for computational biology and bioinformatics [J].

Gentleman, RC ;

Carey, VJ ;

Bates, DM ;

Bolstad, B ;

Dettling, M ;

Dudoit, S ;

Ellis, B ;

Gautier, L ;

Ge, YC ;

Gentry, J ;

Hornik, K ;

Hothorn, T ;

Huber, W ;

Iacus, S ;

Irizarry, R ;

Leisch, F ;

Li, C ;

Maechler, M ;

Rossini, AJ ;

Sawitzki, G ;

Smith, C ;

Smyth, G ;

Tierney, L ;

Yang, JYH ;

Zhang, JH .

GENOME BIOLOGY, 2004, 5 (10)

← 1 2 3 4 5 6 7 8 →